Article

Genomic surveillance at scale is required to detect newly emerging strains at an early timepoint

2021-01-15

Abstract excerpt

Genomic surveillance in the setting of the coronavirus disease 2019 (COVID-19) pandemic has the potential to identify emerging SARS-CoV-2 strains that may be more transmissible, virulent, evade detection by standard diagnostic tests, or vaccine escapes. The rapid spread of the SARS-CoV-2 B.1.1.7 strain from southern England to other parts of the country and globe is a clear example of the impact of such strains. E...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e46dd09c-a15d-5485-8aca-84b2041598fe
DOI: 10.1101/2021.01.12.21249613

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic surveillance at scale is required to detect newly emerging strains at an early timepointDOI 10.1101/2021.01.12.21249613Read

Low Testing Rates Limit the Ability of Genomic Surveillance Programs to Monitor SARS-CoV-2 Variants: A Mathematical Modelling StudySemantic proximity Read

SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programsSemantic proximity Read

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort studySemantic proximity Read

Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic dataSemantic proximity Read

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7Semantic proximity Read

The analysis of a large dataset of PCR-test results in the community reveals the impact of age, variants and vaccination status on SARS-CoV-2 viral dynamicsSemantic proximity Read

Cost Effective Proactive Testing Strategies During COVID-19 Mass Vaccination: A Modelling StudySemantic proximity Read

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in SwitzerlandSemantic proximity Read

Framework to estimate the cost-effectiveness of the Genome Sequencing-based surveillance network: an integrated operational model-epidemiological model approachSemantic proximity Read

Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variantsSemantic proximity Read

Using viral genomics to estimate undetected infections and extent of superspreading events for COVID-19Semantic proximity Read

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021Semantic proximity Read